Marck To Enter Malaysia, S’pore & Indonesia Markets

The Ahmedabad based Pharmaceutical company Marck Biosciences Ltd. is all set to foray into the Far East countries like Malaysia, Singapore and Indonesian markets by the end of June 2008. The company is planning to offer 12 new products in the existing therapeutic segment and these markets.

The company has wide therapeutic products in the domestic as well as international market. Its large volume parenterals segment offers a complete range of common solutions, electrolyte replacements, antibiotic solutions, diuretics anti infective and anti fungal solutions. Whereas, its small volume parentearls range provides diluents, ophthalmic and respiratory solutions.

In a telephonic interaction with Pharmabiz, Bhavesh Patel, MD, Marck Biosciences Ltd, said, "We have filed 12 new dossiers in Malaysia, Singapore and Indonesia and are expected to get approvals from the respective authorities by the end of June 2008. All our 12 new products will be for the ophthalmic and injection therapeutic segment.

(Ref: The Chronicle Pharmabiz dated April 3, 2008)